Protocol No.

169175 (CP-AU-007-01)

Principal Investigator

Hu-Lieskovan, Siwen

Phase

I/II

Age Group

Adult

ClinicalTrials.Gov

NCT05267626 (Click to jump to clinicaltrials.gov)

Title

Phase I/II, First-in-Human, Open Label, Dose Escalation and Expansion Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2R? Binding, in Patients with Unresectable Locally Advanced or Metastatic Cancer

Objective